Endothelial nitric oxide synthase gene and the development of diabetic nephropathy

Diabetes Research and Clinical Practice

Volumn 58, Issue 3, 2002, Pages 179-185

  Shimizu, Tomoaki ^a   Onuma, Tomio ^a   Kawamori, Ryuzo ^a   Makita, Yuichiro ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Constitutive endothelial nitric oxide synthase gene; Diabetic nephropathy; Japanese; Type 2 diabetes mellitus

Indexed keywords

NITRIC OXIDE SYNTHASE;

ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; HUMAN; INTRON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ALBUMINURIA; BASE SEQUENCE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; INTRONS; JAPAN; MALE; MUTAGENESIS, INSERTIONAL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; REFERENCE VALUES; REGRESSION ANALYSIS; RISK FACTORS; SEQUENCE DELETION;

EID: 0036972917     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(02)00156-0     Document Type: Article

References (26)

1. A.S. Kolewski, J.H. Warram, Christlieb et al., The changing natural history of nephropathy in type 1 dibetes, Am. J. Med. 78 (1985) 785-794.
2. Andersen A.R., Christiansen P.K., Andersen J.K., et al. T: Diabetic nephropathy in IDDM diabetes, an epidemiological study. Diabetologia. 25:1983;496-501.
3. Krolewski A.S., Warram J.H., Christlieb A.R., et al. Epidemiological approach to studies on etiology of IDDM and its complications. N. Engl. J. Med. 317:1987;140-145.
4. Seaquist E.R., Goetz F.C., Rich S., Barbosa J. Familiar clustering of diabetic nephropathy. N. Engl. J. Med. 320:1989;1161-1165.
5. Pettitt D.J., Saad M.F., Bennett P.M., et al. Familiar predisposition to renal disease in two generations of Pima Indians with type 2 non-insulin dependent diabetes mellitus. Diabetologia. 33:1990;438-440.
6. Quinn M., Angelico M.C., Warram J.H., Krolewski A.S. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 39:(8):1996;940-945.
7. Tsukada T., Yokoyama K., Arai T., et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Bicchem. Biophys. Res. Commun. 245:1998;190-193.
8. Simmons J.I., Provoost A.P., Anderson S., et al. Modulation of glomerulohypertension defines susceptibility to progressive glomerular injury. Kidney Int. 46:1994;396-404.
9. Tolins P., Shults P.J., Raij L., et al. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am. J. Physiol. 265:1993;F886-F895.
10. Kone B.C., Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am. J. Physiol. 272:1997;F561-F578.
11. Raij L., Baylis C. Glomerular actions of nitric oxide. Kidney Int. 48:1995;20-23.
12. Komers R., Allen T.J., Cooper M.E. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes. 43:1994;1190-1194.
13. Sugimoto H., Shikata K., Matsuda M., et al. Increased expression of endothelial cell nitric oxide synthase in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia. 41:1998;1426-1434.
14. Chiarlli F., Cipllone F., Romano F., et al. Increased circulating nitric oxide in young patients with type 1 diabeties and persistent microalubuminuria (relation to glomerular hyperfiltration). Diabetes. 49:2000;1258-1263.
15. Bank N., Aynedjian H.S. Role of EDRF in diabetic renal hyperfiltration. Kidney Int. 43:1993;1306-1312.
16. Reyes A.A., Karl I.E., Kissance J., Klahr S. L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J. Am. Soc. Nephrol. 4:1993;1039-1045.
17. Corbett J.A., Tilton R.G., Chang K., et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes. 41:1992;552-556.
18. Cosentino F., Hishikawa K., Katusic Z.S., Luscher T. High glucose increases nitric oxide syntase expression and superoxide anion generation in human aortic endothelial cells. Circulation. 96:1997;25-28.
19. Zanchi A., Moczulski D.K., Hanna L.S., et al. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 57:2000;405-413.
20. Neugebauer S., Tsuneharu B., Tsuyoshi W. Association of the nitric oxide synthase gene polymorphism with an increased risk for development to diabetic nephropathy in type 2 diabetes. Diabetes. 49:(3):2000;500-503.
21. Fujita H., Narita T., Meguro H., et al. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Horm. Metab. Res. 32:2000;80-83.
22. Nadaud S., Bonnardeaux A., Lathrop M., Soubrier F. Gene structure polymorphism and mapping of the human endothelial nitric oxide syntase gene. Biochem. Res. Commun. 198:1994;1027-1033.
23. Marsden P.A., Heng H.H., Scherer S.W., et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268:1993;17 478-17 488.
24. Miyahara K., Kawamoto T., Sase K., et al. Cloning and structural characterization of the human endothelial nitric oxide synthase gene. Eur. J. Biochem. 223:1994;719-726.
25. Wang X.L., Sim A.S., Badenhop R.F., et al. A smoking dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 2:1996;41-45.
26. Borch J.K., Anderson P.K., Deckert T. The effect of proteinuria on relative mortality in insulin dependent diabetes (an epidemiological study). Diabetologia. 25:1983;496-501.